Ajinomoto

Last updated January 31, 2026

Innovation Areas

1,635

Inventors

Collaborations

Bioactive micronutrient chelation complexes: AjinomotoRecent Research Landscape

Systemic iron deficiency and oxidative stress drive neurological decline and anemia. These compositions stabilize iron transport and absorption to mitigate cognitive impairment and cerebral atrophy.

What technical problems is Ajinomoto addressing in Bioactive micronutrient chelation complexes?

Chemotherapy induced muscle degradation

(6)evidences

Neurological deterioration and cerebral atrophy lead to functional impairment. Arresting these degradation mechanisms prevents loss of executive and emotional stability.

Inadequate micronutrient bioavailability

(5)evidences

Insufficient systemic iron levels and pathological sugar-induced protein damage. Addressing these prevents metabolic dysfunction and hematological failure.